Pages that link to "Q38479413"

The following pages link to Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma (Q38479413):

Displaying 44 items.

• Hippo/YAP pathway for targeted therapy (Q28088294) (← links)
• A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer (Q28140913) (← links)
• Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma (Q28397153) (← links)
• No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas. (Q30321283) (← links)
• Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines. (Q33290349) (← links)
• Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines (Q33648515) (← links)
• Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma (Q33680576) (← links)
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma (Q34293053) (← links)
• Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma (Q34353359) (← links)
• Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis. (Q34639436) (← links)
• Peritoneal mesothelioma (Q34678683) (← links)
• Advances in the management of malignant mesothelioma (Q35142860) (← links)
• Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma (Q35604575) (← links)
• High frequency of aberrant p16(INK4A) expression in human breast cancer (Q35782316) (← links)
• Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile (Q36252181) (← links)
• Loss of functional pRB is not a ubiquitous feature of B-cell malignancies (Q36617740) (← links)
• G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder (Q36618000) (← links)
• Update on the molecular biology of malignant mesothelioma (Q36755500) (← links)
• Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice (Q37101238) (← links)
• Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis (Q37150740) (← links)
• Molecular biology of malignant mesothelioma (Q37232301) (← links)
• Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. (Q37287506) (← links)
• Translational therapies for malignant pleural mesothelioma. (Q37734455) (← links)
• Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation (Q37880216) (← links)
• Pathological and molecular biological approaches to early mesothelioma (Q37975137) (← links)
• Expression of p 16 protein in prostatic adenocarcinomas, intraepithelial neoplasia, and benign/hyperplastic glands (Q38475192) (← links)
• FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line (Q38780904) (← links)
• Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients. (Q38888134) (← links)
• Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma (Q39399033) (← links)
• Inactivation of p16INK4a expression in malignant mesothelioma by methylation (Q40694393) (← links)
• Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. (Q40953387) (← links)
• Lovastatin induces apoptosis in malignant mesothelioma cells. (Q41039948) (← links)
• CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies (Q41404471) (← links)
• Molecular diagnosis of pancreas carcinoma (Q41528285) (← links)
• Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. (Q42130716) (← links)
• Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression (Q42850901) (← links)
• Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. (Q43247519) (← links)
• Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer (Q44574851) (← links)
• The p16INK4a/CDKN2A tumor suppressor and its relatives. (Q54317457) (← links)
• Diffuse malignant mesothelioma of the peritoneum (Q61794228) (← links)
• p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways (Q64380907) (← links)
• Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas (Q73622335) (← links)
• Molecular biology of lung cancer (Q77224978) (← links)
• Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma (Q90390482) (← links)